Amikacin
2 results
Applied filters
Amikacin: informing intrathecal risk assessment
5 August 2025Amikacin products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Implementing pharmacogenomic testing for aminoglycosides
10 June 2025Patients with mitochondrial variants have an increased risk of deafness with amikacin, gentamicin, neomycin and tobramycin. Guidance on testing is provided.